Company Profile

Company Description

Sio Gene Therapies Inc. is a clinical-stage biotechnology company focused on developing innovative gene therapies for severe neurological disorders. Their research primarily targets conditions like GM1 gangliosidosis and GM2 gangliosidosis, rare genetic diseases affecting the central nervous system. Utilizing advanced gene transfer technologies, the company aims to restore normal cellular function by delivering therapeutic genes. Their approach holds promise for patients with limited treatment options, emphasizing safety and efficacy in clinical trials. The company collaborates with leading researchers and institutions to advance its pipeline, striving to bring transformative treatments to underserved populations. Their work represents a significant step forward in precision medicine for neurodegenerative diseases.